Global Drug Retail

Product Code DAT01583
Publication Date June 2010
Publisher Datamonitor
Product Type Report
Pages 34
ISBN Number not applicable
Change currency
PDF £160.00 €193 $253 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Global Drug Retail

Datamonitor's Global Drug Retail industry profile is an essential resource for top-level data and analysis covering the Drug Retail industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

  • Contains an executive summary and data on value, volume and/or segmentation
  • Provides textual analysis of Global Drug Retail's recent performance and future prospects
  • Incorporates in-depth five forces competitive environment analysis and scorecards
  • Includes a five-year forecast of Global Drug Retail
  • The leading companies are profiled with supporting key financial metrics
  • Supported by the key macroeconomic and demographic data affecting the market

Highlights

  • Detailed information is included on market size, measured by value and/or volume
  • Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
  • Market shares are covered by manufacturer or brand

Why you should buy this report

  • Spot future trends and developments
  • Inform your business decisions
  • Add weight to presentations and marketing materials
  • Save time carrying out entry-level research

Market Definition

The drug retail sector consists of the total revenues generated through the sales of all prescription drugs and over the counter medicines via outlets for which drug retail is the primary revenue source.

The sector is valued at retail selling price (RSP) with any currency conversions calculated using constant 2009 average exchange rates.

For the purposes of this report, the global market consists of North America, South America, Western Europe, Eastern Europe, and Asia-Pacific.

Contents

  • Table of Contents
  • Executive Summary
  • Market Overview
    • Market definition
    • Research highlights
    • Market analysis
  • Market Value
  • Market Segmentation I
  • Market Segmentation Ii
  • Market Share
  • Five Forces Analysis
    • Summary
    • Buyer power
    • Supplier power
    • New entrants
    • Substitutes
    • Rivalry
  • Leading Companies
    • CVS
    • Rite Aid
    • Walgreen
  • Market Forecasts
    • Market value forecast
  • Appendix
    • Methodology
    • Industry associations
    • Related Datamonitor research
    • Disclaimer
  • about Datamonitor
    • Premium Reports
    • Summary Reports
    • Datamonitor consulting
  • List of Tables
    • Table 1: Global drug retail sector value: $ billion, 2005-09
    • Table 2: Global drug retail sector segmentation I:% share, by value, 2009
    • Table 3: Global drug retail sector segmentation II: % share, by value, 2009
    • Table 4: Global drug retail sector share: % share, by value, 2009
    • Table 5: CVS: key facts
    • Table 6: CVS: key financials ($)
    • Table 7: CVS: key financial ratios
    • Table 8: Rite Aid: key facts
    • Table 9: Rite Aid: key financials ($)
    • Table 10: Rite Aid: key financial ratios
    • Table 11: Walgreen: key facts
    • Table 12: Walgreen: key financials ($)
    • Table 13: Walgreen: key financial ratios
    • Table 14: Global drug retail sector value forecast: $ billion, 2009-14
  • List of Figures
    • Figure 1: Global drug retail sector value: $ billion, 2005-09
    • Figure 2: Global drug retail sector segmentation I:% share, by value, 2009
    • Figure 3: Global drug retail sector segmentation II: % share, by value, 2009
    • Figure 4: Global drug retail sector share: % share, by value, 2009
    • Figure 5: Forces driving competition in the global drug retail sector, 2009
    • Figure 6: Drivers of buyer power in the global drug retail sector, 2009
    • Figure 7: Drivers of supplier power in the global drug retail sector, 2009
    • Figure 8: Factors influencing the likelihood of new entrants in the global drug retail sector, 2009
    • Figure 9: Factors influencing the threat of substitutes in the global drug retail sector, 2009
    • Figure 10: Drivers of degree of rivalry in the global drug retail sector, 2009
    • Figure 11: CVS: revenues & profitability
    • Figure 12: CVS: assets & liabilities
    • Figure 13: Rite Aid: revenues & profitability
    • Figure 14: Rite Aid: assets & liabilities
    • Figure 15: Walgreen: revenues & profitability
    • Figure 16: Walgreen: assets & liabilities
    • Figure 17: Global drug retail sector value forecast: $ billion, 2009-14